Heartflow (HTFL) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartflow (HTFL) has outperformed Stevanato Group S.p.A. (STVN) over the past year, gaining 41.1% versus a loss of 19.2%. Stevanato Group S.p.A. is the larger company by market cap ($5.31 billion vs $4.29 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HTFL | STVN |
|---|---|---|
| Share price | $49.36 | $19.44 |
| Market cap | $4.29B | $5.31B |
| 1-day change | -2.62% | -2.11% |
| YTD return | +69.33% | -3.38% |
| 1-year return | +41.07% | -19.20% |
| 5-year return | — | -20.07% |
| P/E ratio (TTM) | — | 34.71 |
| Forward P/E | — | 23.10 |
| EPS (TTM) | $-0.23 | $0.56 |
| Dividend yield | 0.00% | 0.32% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $176.03M | — |
| Revenue growth (YoY) | +39.92% | — |
| Net income (latest FY) | $-116.79M | — |
| Gross margin | 76.80% | — |
| Operating margin | -36.39% | — |
| Net margin | -66.35% | — |
| 52-week high | $54.32 | $27.99 |
| 52-week low | $20.13 | $12.89 |
| Distance from 52-week high | -9.13% | -30.55% |
| Analyst consensus | none | buy |
| Avg. price target upside | -6.81% | +26.95% |
| Average volume | 1.79M | 370.47K |
| Shares outstanding | 86.95M | 49.83M |
| Employees | 843 | 6,010 |
| Sector | Healthcare | Health Care |
| Industry | Health Information Services | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HTFL has outperformed STVN by 60.3 percentage points over the past year.
- The two companies sit in different sectors: Heartflow in Healthcare and Stevanato Group S.p.A. in Health Care.
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Healthcare · Health Information Services · 843 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
HTFL vs STVN FAQ
Which is bigger, Heartflow or Stevanato Group S.p.A.?
Stevanato Group S.p.A. (STVN) is larger, with a market capitalization of $5.31B compared with $4.29B for Heartflow (HTFL).
Which stock has performed better over the past year, HTFL or STVN?
HTFL returned +41.07% over the past 12 months, compared with -19.20% for STVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Heartflow or Stevanato Group S.p.A.?
Stevanato Group S.p.A. pays a dividend yielding 0.32%, while Heartflow does not currently pay a regular dividend.
Are Heartflow and Stevanato Group S.p.A. in the same industry?
No. Heartflow is in the Healthcare sector, while Stevanato Group S.p.A. is in Health Care.